跳至主要内容
临床试验/NCT01280630
NCT01280630已完成不适用

A Multicentre Retrospective Study to Understand Anti-thrombotic Treatment Patterns and Outcomes of Acute Coronary Syndrome (ACS) Patients in India

AstraZeneca1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2011年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
500
试验地点
1
主要终点
Anti-thrombotic treatment strategies in a 'real-life' observational setting across different sites in India.

研究概览

简要总结

TRACE is a Multicentre Retrospective Study planned to gather follow up data for a period of 1 year in order to understand anti-thrombotic management patterns and outcomes of Acute Coronary Syndrome patients in India.

This retrospective study is designed to provide a rapid and quick analysis of the existing database of ACS patients. So as to ensure quality check in the study, a pilot study will be conducted with around 500 patients at 10 centres across India and based on the meaningful results of the pilot study, full retrospective multi-centric study will be initiated at various selected centres across India. This study will use available registry data from a defined time period of Jan 2007-Dec 2009.

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients of the age of 18 years or older and hospitalized for ACS within the previous 3 years.
  • Diagnosis of STEMI, NSTEMI or UA using Standard and Universal Definition of Myocardial Infarction

排除标准

  • UA, STEMI and NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or post-PCI.
  • UA, STEMI and NSTEMI occurring in patients already hospitalized for other reasons

结局指标

主要结局

Anti-thrombotic treatment strategies in a 'real-life' observational setting across different sites in India.

时间窗: Jan 2007-Dec 2009

Anti thrombotic strategies used in ACS patients

时间窗: Jan 2007-Dec 2009

次要结局

  • ACS outcomes with respect to: -Revascularization -Angina/ Re-infarction -Cardiogenic shock/Heart failure/Cardiac arrest -Atrial fibrillation/flutter -Ventricular Fibrillation/ Sustained V Tachycardia -Stroke -Mortality -Bleeding(Jan 2007-Dec 2009)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验